Pharmacogenomics is a rapidly growing field with enormous potential for improving patient care. It is already being used in clinical practice for drugs such as warfarin and cetuximab, and is being used to develop new drugs for specific genetic profiles. As the field of pharmacogenomics continues to advance, it has the potential to transform how we approach drug development and patient care.

Pharmacogenomics (PGx) is the study of how genetic differences influence a person's reaction to drugs. In one study, more than 99% of those tested had a genotype linked to an increased risk of at least one medicine. Pharmacogenomics research findings can enhance future results for both patients and healthcare providers by improving medication safety and efficacy and lowering medical expenses. Pharmacogenomics, also known as pharmacogenetics, is the study of how genes influence the body's response to drugs. Pharmacogenomic testing are available for persons who are taking medications for depression, anxiety, or certain forms of cancer.

Discover More- https://cmiblogdailydose.blogspot.com/2023/04/pharmacogenomics-can-be-used-for.html